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The Fas receptor-ligand system is a major regulator of apoptosis
and its malfunction can contribute to tumor growth, metastasis,
and immune system evasion [1]. Fas (CD95/APO-1/TNFRSF6), a
member of the tumor necrosis factor (TNF) receptor superfamily,
is a glycosylated transmembrane protein with an apparent molec-
ular weight of approximately 45–52-kDa. Fas apoptosis can be trig-
gered by the binding with its ligand (FasL/CD178/TNFSF6), forming
the death-inducing signaling complex (DISC) upon the recruitment
of Fas associated death domain (FADD) and procaspase-8. The ac-
tive caspase-8 generated from the DISC cleaves Bid and the result-
ing truncated Bid (tBid) stimulates the release of cytochrome c
from the mitochondria, formation of the apoptosome and the acti-
vation of caspase-9, which cooperates with caspase-8 to activate
caspase-3. In some cells, active caspase-8 is sufﬁcient to activate
the executioner caspase-3, which cleaves certain structural and
regulatory proteins, leading to apoptosis [2].chemical Societies. Published by E
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.Several early molecular events leading to the DISC formation
have been recently described. These include the localization of
Fas in the raft nanodomains [3–5] which is mediated by Fas palm-
itoylation [6], the activation-induced formation of SDS- and b-
mercaptoethanol-stable aggregates (in short, SDS-stable) [7–9],
and the receptor internalization [10–12] by clathrin-mediated
pathway which allows an efﬁcient formation of the DISC and thus
apoptosis [11,12]. Previously, the internalization of activated Fas
was believed to downregulate its signal through its removal from
the cell surface for degradation. However, recent evidence that a
signal ampliﬁcation process intervenes during apoptosis suggests
that rather than being rapidly degraded, following internalization
and during the execution of apoptosis, the receptor may play cer-
tain roles, that have yet to be identiﬁed.
During apoptosis, cytoplasmic trafﬁcking of molecules and cel-
lular reorganization (cell shape, polarity, and movements) are
coordinated by cytoskeletal elements which interact intimately
with membrane-associated proteins [13,14]. Studies including
ours have demonstrated that the internalization of Fas is cytoskel-
eton-dependent [6,10], and requires the receptor’s association with
the actin cytoskeleton via the membrane protein/cytoskeleton-lin-
ker, ezrin [6,12].
Herewe describe the fate of Fas downstreamof the FasL-induced
internalization step, including formation of a caspase-dependent
SDS-stable Fas complex which is mediated by the integrity of the
cytoskeleton, and particularly, the selective role of microtubular
components in the organization of a subset of Fas complexes.lsevier B.V. All rights reserved.
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2.1. Antibodies and reagents
The human recombinant FasL was purchased from Alexis Cor-
poration (Nottingham, UK). The IgFasL was a gift from Drs. J.L
Taupin and P. Legembre (CNRS UMR5540, Bordeaux, France).
Anti-actin and anti-Flag (M2) antibodies were from Sigma–Al-
drich (St. Louis, MO, USA), and anti-b-tubulin from Invitrogen
(Carlsbad, CA, USA). Unless indicated in the ﬁgure legends, the
Abcam (Cambridge, UK) antibody against extracellular mouse
Fas was used in all immunoblotting experiments. The 7C10 anti-
body from Millipore (Billerica, MA, USA) was used to detect the
Fas intracellular domain and for Fas immunoprecipitation (IP)
experiments. FITC-conjugated anti-Fas antibody (JO2-FITC) was
purchased from BD Bioscience (San Jose, CA). Additional antibod-
ies and reagents are listed in the Supplementary materials and
methods.
2.2. Cell lines
Stable L12.10.3 cells expressing murine Fas (L1210.mFas and
L1210.mFas-GBM) were established as described [6,12]. Thymo-
cytes were isolated from spleens of a 6–10-week-old Balb/c mouse.
The cells were maintained in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) (Invitrogen) with 5% fetal calf serum at 37 C, 5% CO2.
2.3. Total lysate preparation
Cells were incubated with 100 ng/ml FasL (or indicated) plus
1 lg/ml M2 or IgFasL at 37 C in the presence of 10 mM HEPES.
After washing with PBS, cells were lysed with Laemmli buffer. Pro-
tein concentrations were determined using Bio-Rad Dc protein as-
say. 2-b-Mercaptoethanol (5%) was added and lysates were heated
for 5 min at 95 C before SDS–PAGE and immunoblotting. Quanti-
ﬁcation of band intensity was performed using Image J version
1.37i software. Results are presented as relative numbers from
which the background intensity is subtracted.
2.4. Cell death assays
2.4.1. Sub-G1 measurement
Cells were ﬁxed in ice-cold 70% ethanol, washed in 38 mM cit-
rate buffer (pH 7.4) and incubated for 20 min in 38 mM citrate
supplemented with 69 lM propidium iodide (PI) and 5 lg/ml
RNaseA. Cells were analyzed with a FACS Calibur ﬂow cytometer
(Becton Dickinson) and the proportion of sub-G1 particles was
determined.2.4.2. Membrane integrity
Cells were stained with PI (5 lg/ml) before analyzing with a
ﬂow cytometer.
2.5. Cytoskeleton isolation
Cytoskeleton isolation was performed as previously described
[6] with slight modiﬁcations. Brieﬂy, cells were solubilized for
10 min in lysis buffer (0.5% Triton X-100, protease inhibitors cock-
tail, 3 mM Na3VO4, 20 mM EGTA and 50 mM HEPES pH 7.4) at
room temperature. The insoluble pellet was washed once with
the lysis buffer to obtain the cytoskeleton fraction. Protein concen-
trations were determined and fractions were analyzed by immuno-
blotting. To perform the co-IP, the cytoskeleton fraction was
resuspended in lysis buffer, sonicated and then immunoprecipi-
tated with anti-tubulin or anti-Fas antibody coupled to protein Gsepharose beads at room temperature for 3 h. The beads were
washed six times with lysis buffer and the immunoprecipitates
were eluted from beads with Laemmli buffer at 95 C for 5 min
and subjected to SDS–PAGE and immunoblotting.3. Results and discussion
3.1. Distinct SDS-stable Fas complexes are formed during FasL-induced
apoptosis
Since the internalization of Fas can lead to the ampliﬁcation
of the apoptotic signal rather than downregulation, the fate of
Fas may be other than its lysosomal degradation. To study the
fate of Fas, we used immunoblotting to investigate its protein
expression. Three types of cells (mouse thymocytes, L1210 cells
which are mouse T cells lacking Fas surface expression and
L1210.mFas cells which stably express mouse Fas) were treated
with FasL crosslinked with anti-FLAG. The surface expression of
Fas in these cells is shown in Fig. 1A. Using antibody against
the extracellular domain of mouse Fas, we observed in L1210
cells bands at 170 and 108-kDa but not at the 45/48-kDa
where Fas monomers are expected (Fig. 1B upper panel). Expres-
sion of Fas in the L1210.mFas cells led to an increase of the 45/
48-kDa forms along with the 56- and 170-kDa complexes.
The expression of the 45/48-, 56-, 108-, and 170-kDa forms
of Fas were also observed in thymocytes. The basal immunode-
tection of these Fas forms by the antibody against the extracel-
lular domain of Fas is consistent with Fas bands detected in
mouse cerebral cortex with an antibody against the C-terminal
region [15]. With the increase in the activation time, we noted
the disappearance of the 170- and 108-kDa bands, in parallel
with the appearance of 140- and 86/89-kDa bands in
L1210.mFas cells (see immunoblot intensity quantiﬁcation,
Fig. 1C) and in thymocytes, as well as the increase in 45-kDa/
48-kDa ratio in L1210.mFas cells. These changes occurred con-
comitantly with the increase in apoptosis (presented as % sub-
G1 population which correlates to the DNA fragmentation,
Fig. 1B lower panel). In the Fas surface-negative L12.10.3 cells
which are resistant to FasL-induced apoptosis, such changes in
expression pattern were not observed.
To ensure that the Fas expression pattern were not an artifact of
the use of anti-FLAG antibody to crosslink FasL, we employed
IgFasL, a chimera of FasL and the Ig-like module of the LIF receptor
gp190 [16], which triggers Fas apoptosis without antibody cross-
linking. The treatment of L1210.mFas cells with IgFasL provided
similar results as crosslinked FasL. This indicates that the distinct
Fas expression pattern is a general outcome of apoptosis triggered
by FasL and not an experimental artifact (Fig. 2A). We also ob-
served that unlike with FasL treatment, H2O2 treatment did not in-
duce the formation of the 86/89- and 140-kDa complexes nor
the decrease of the 170- and 108-kDa complexes (Fig. 2B).
These ﬁndings indicate that the dynamic changes in the Fas
expression pattern, which include the diminution of the 170-
and 108-kDa complexes along with the appearance of the
140- and 86/89-kDa complexes and the increase in the ratio
of 45/48-kDa doublets, are characteristic of apoptosis triggered
by the receptor ligation.
As the expression levels of the56-kDa bands were not affected
by the cell death induction methods used, we considered that they
were not actively involved and henceforth focused on the 170-
and 140-kDa (higher complex), 108- and 86/89-kDa (lower
complex), and 45/48-kDa (monomer) forms.
Using antibodies against the extracellular and intracellular do-
main of mouse Fas, we detected the disappearance of both 170-
and 108-kDa complexes and the appearance of 86/89-kDa
Fig. 1. Formation of distinct SDS-stable Fas complex pattern of during FasL-induced apoptosis in murine cells. Mouse Fas surface expression is measured by FACS following a
staining with a ﬂuorescence-conjugated monoclonal antibody against the extracellular domain of Fas (solid line, JO2-FITC-stained; dashed line, control unstained) (A). Cells
treated with M2-crosslinked FasL for the indicated times were subjected to immunoblotting with indicated antibodies (a typical experiment of 8 is shown) and cell death
assessment by sub-G1 measurement. The graph represents the average of three independent cell death experiments, with error bars indicating S.D. (B). Quantiﬁcation of band
intensity on L1210.mFas cells was performed by Image J software (C). We marked the disappearance of the 170- and 108-kDa bands with black arrows, the appearance of
140- and 86/89-kDa bands with white arrows and the presence of the monomer Fas with a star.
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intracellular antibody. These ﬁndings suggest that the 170- and
108- and 86/89-kDa SDS-stable complexes contain the whole
uncleaved Fas protein.
The immunodetection of SDS-stable Fas complexes of 200–
250-kDa with antibodies against the C-terminus of Fas has been
reported in human cell lines following the activation with Fas
agonistic antibodies [7–10,16]. When crosslinked FasL was used
to activate human cell lines, we could not detect complexes of
170-kDa with the antibody against the C-terminus of Fas
(Fig. S2). This is consistent with the previous report of the ab-
sence of 200–250-kDa forms when crosslinked FasL or IgFasL
were used [16]. However, similarly with our observation in
mouse cells, we detected the formation of the 86/89- and
120-kDa forms, and the reduction of the 108-kDa form. These
changes also occurred concomitantly with the detection of apop-
tosis (Fig. S2A). Our observations suggest that such expression
patterns may be found during the FasL-induced apoptosis in var-
ious cell types.3.2. Fas SDS-stable complex formation occurs downstream of the DISC
formation and requires caspase activities
As the caspase cascade is central to apoptosis, we examined the
involvement of caspases in the formation of Fas complexes using
pharmacological inhibitors. Using a pancaspase inhibitor and spe-
ciﬁc inhibitors of initiator caspases-8 and -9, and executioner cas-
pase-3, at doses that efﬁciently inhibited apoptosis, we found that
the FasL-induced Fas complex pattern could be reversed. This in-
cluded the disappearance of the 170-kDa and the appearance of
140-kDa forms (higher complex group), the disappearance of
the 108-kDa and the appearance of 86/89-kDa forms (lower
complex group), and the increased 45-kDa/48-kDa ratio (monomer
group). However, the caspase-3 inhibitor could only efﬁciently re-
verse the pattern in the lower complex and the monomer groups
(Fig. 3A). These results suggest that the systematic FasL-induced
Fas complex pattern took place downstream of the activation of
the initiator caspases. The fact that inhibitors of caspases-8 and
-9 could reverse the complex pattern suggests that this process
Fig. 2. The formation of SDS-stable Fas complexes is speciﬁc for FasL-induced apoptosis. L1210.mFas cells treated with M2-crosslinked FasL or IgFasL for 3 h were subjected
to immunoblotting with indicated antibodies (a typical experiment of 5 is shown) and cell death assessment by sub-G1 measurement. The graph represents the average of
three independent cell death experiments, with error bars indicating S.D. (A). L1210.mFas cells were treated with H2O2 for 16 h and then subjected to immunoblotting with
indicated antibodies (a typical experiment of 3 is shown) and cell death assessment based on plasma membrane integrity by PI exclusion method. The graph represents the
average of three independent cell death experiments, with error bars indicating S.D. (B).
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apoptosome. The use of the caspase-3 inhibitor further revealed
that only the lower complex and the monomer patterns (108-,
86/89-kDa, and 45/48-kDa forms) occur downstream of the exe-
cutioner caspase activation whereas the higher complex pattern
(170- and 140-kDa forms) takes place upstream.
To conﬁrm the stage where such Fas complex formation takes
place using a genetic approach, we used the Fas expressing
L1210 cells whose glycosphingolipid-binding motif was disrupted
by a point mutation Y130A in the extracellular domain
(L1210.mFas-GBM). We have previously shown that the FasL
engagement in L1210.mFas cells leads to the clathrin-dependent
internalization of the activated Fas, which allows the DISC forma-
tion and the ampliﬁcation of apoptotic signaling. In contrast, the
FasL engagement in L1210.mFas-GBM cells leads to clathrin-inde-
pendent internalization of the activated receptor, which com-
pletely suppresses the DISC formation and thus the apoptotic
signal while promoting non-death signals such as MAPK activation
and proliferation [12]. And unlike in L1210.mFas cells, the changes
in the SDS-stable Fas complexes were completely inhibited along
with FasL-induced apoptosis in the L1210.mFas-GBM cells
(Fig. 3B). This ﬁnding suggests that the distinct Fas complex pat-
tern occurs downstream of the receptor internalization via the
clathrin-mediated pathway that permits DISC formation.
Using an antibody against the C-terminus of Fas, we also de-
tected a pattern in human cells that resembles what occurs in mur-
ine cells, namely, the formation of the 86/89- and 120-kDa
forms, and the reduction of the 108-kDa form during FasL-in-
duced apoptosis (Fig. S2A). This pattern could be inhibited in the
absence of FADD as observed in FADD-negative Jurkat cells
(Fig. S2B). This provides additional genetic evidence that the for-
mation of this Fas complex pattern depends on the DISC formation,
which is consistent with the requirement for caspase activation to
form similar complexes in the murine cells.During apoptosis induced by Fas agonistic antibody in human
cell lines, after the formation of the 200–250-kDa bands, a 97-
kDa band was detected by antibodies against Fas death domain
and C-terminus. This 97-kDa band is suggested to be a processed
form of Fas lacking the extracellular domain as it could not be
immunoprecipitated by a Fas extracellular domain antibody [8].
Although this band appeared at the same kinetics as the caspase-
3 activation and poly(ADP-ribose) polymerase cleavage, its appear-
ance could not be inhibited by inhibitors of caspases, calpain, or
proteasome [8]. We did not observe this band despite the detection
with the same intracellular antibody as in that previous report
(Fig. S2A). This discrepancy suggests that the Fas complexes we de-
tected were originated by a different mechanism from that of the
previous study. This may be attributed to the stimuli used to in-
duce Fas apoptosis since the difference in apoptotic mechanisms
triggered by FasL and Fas agonistic antibodies has been reported
[16–19].
Our immunoblots indicating that the appearance of the 140-
and 86/89-kDa forms occurs in parallel with the disappearance
of the 170- and 108-kDa forms in a caspase-dependent manner
suggests several possibilities: (1) Fas in the 170-kDa complexes is
processed by caspases-8 and -9 and Fas in the 108-kDa complex
is processed by caspase-3 to form the 140- and 86/89-kDa
forms, respectively, (2) there are changes in Fas conformation that
lead to the change in the complex sizes, and/or, (3) other mole-
cules, possibly direct substrates of caspases-8 and -9 and cas-
pase-3, that form SDS-stable complexes with Fas are cleaved by
corresponding caspases to yield the smaller, processed complexes.
Our observation when an intracellular Fas antibody was used
for the immunoblot (Figs. S1 and S2) supports the probability that:
(1) the 170-kDa form might be processed into the 140-kDa
form, which contains only the extracellular fragment because it
could only be detected with the extracellular (and not the intracel-
lular) Fas antibody and (2) the 86/89-kDa complex might com-
Fig. 3. Caspase activities are required for Fas SDS-stable complex formation. L1210.mFas cells were pretreated for 30 min with different doses of caspase inhibitors and then
incubated with M2-crosslinked FasL for 5 h before immunoblotting (a typical experiment of 5 is shown) and cell death assessment by sub-G1 measurement. The graph
represents the average of three independent cell death experiments, with error bars indicating S.D. (A); L1210.mFas and L1210.mFas-GBM cells were treated with M2-
crosslinked FasL for the indicated times and then subjected to immunoblotting (a typical experiment of 3 is shown) and cell death assessment by sub-G1 measurement. The
graph represents the average of three independent cell death experiments, with error bars indicating S.D. (B).
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mation change and rearrangement of the higher complexes (re-
duced number of Fas molecules or other proteins in the
complexes) since it could be detected with both intracellular and
extracellular Fas antibodies. This should be further investigated.
3.3. Fas lower complexes selectively associate with microtubular
cytoskeleton
The cytoskeleton plays an important role in the Fas apoptotic
process, starting as early as at the receptor ligation and internaliza-
tion stages [6,10] and lasting until the execution phase of apopto-sis. At this late stage, cellular reorganization takes place and
culminates in cellular shrinkage and/or formation of apoptotic
bodies, ready for the engulfment by the phagocytes [13]. Given
our previous ﬁnding that Fas is recruited to the cytoskeleton very
early upon FasL engagement [6], we further examined the involve-
ment of cytoskeleton in the Fas complex arrangement that oc-
curred up until the execution phase of apoptosis. We isolated the
cytoskeleton fraction from the L1210.mFas cells before and after
FasL treatment using Triton X-100 fractionation method [12]. Be-
fore activation, the Fas 108-kDa complex was highly enriched
in the cytoskeleton (Fig. 4A). However after activation, the 86/
89-kDa complex and the 45/48-kDa form became enriched in the
Fig. 4. Selected Fas complexes are associated with tubulin in cytoskeleton fraction. L1210.mFas cells were preincubated for 16 h with or without NDZ before the treatment
with M2-crosslinked FasL for 3 h. Cells were then subjected to the cytoskeleton fractionation and the total lysate and the cytoskeleton fraction were subjected to
immunoblotting. A typical experiment of 3 is shown (A). The quantiﬁcation of the intensity of the higher and lower complexes was carried out on the total lysate (B). Tubulin
co-IP was performed on the cytoskeleton fraction. The total lysate obtained before cytoskeleton fractionation and the immunoprecipitates were then subjected to
immunoblotting. Antibody-conjugated beads served as control for non-speciﬁc detection (ctrl). A typical experiment of 4 is shown (C).
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band was not enriched in the cytoskeleton despite its accumula-
tion in the total lysate after activation. Following the microtubule
depolymerization by nocodazole (NDZ) treatment, which results
in the loss of tubulin from the cytoskeleton, the association of
the lower complexes to the cytoskeleton was greatly reduced
(see immunoblot quantiﬁcation intensity, Fig. 4B). A concomitant
increase in the association of the 45/48-kDa forms to the cytoskel-
eton is observed. These results suggest that the association of the
Fas lower complexes to the cytoskeleton is dependent on the
microtubule integrity and are possibly associated to the microtu-
bular cytoskeleton.
To verify this, we performed tubulin co-IP experiments on
the isolated cytoskeleton. We indeed found a strong association
of the 108-kDa complex to tubulin before activation and of
the 86/89-kDa form after activation, which were reduced fol-
lowing NDZ treatment (Fig. 4C) indicating that the Fas lower
complexes are selectively associated with the microtubular
cytoskeleton.
It has been recently shown that the interphase microtubule ar-
ray, which disassembles at the onset of the execution phase as cen-
trosomal architecture is disrupted, is rapidly replaced by extensive
dynamic bundles. These are important for the relocation of con-
densed chromatin into surface blebs, the cellular fragmentation,
and the interaction of the apoptotic cells with phagocytes [20].
Our ﬁndings that a pool of Fas is associated to microtubules further
highlights the importance of the latter during the execution phase
of FasL-induced apoptosis.3.4. Actin and tubulin play different roles in the Fas complex formation
As both actin and microtubule contribute actively to the apop-
totic process, we wished to distinguish their roles in the Fas com-
plex formation. We treated the L1210.mFas cells with an actin
depolymerizing agent, latrunculin A (LatA) (Fig. S3). We found that
the integrity of actin was required for the disappearance of the
170-kDa form, as demonstrated by the greater detection of these
forms following activation with FasL with an increasing dose of
LatA (see immunoblot quantiﬁcation intensity, Fig. S3). LatA also
reversed the lower complex pattern after FasL treatment by stabi-
lizing the 108-kDa form and reducing the appearance of 86/89-
kDa form while having no effect on the presence of 140-kDa
form. In general, actin depolymerization appears to stabilize the
pre-activation pattern of Fas complexes.
In contrast, the tubulin depolymerization stabilized neither the
higher nor the lower Fas complexes (Fig. 4A and B). The NDZ treat-
ment had a mild effect on the disappearance of the 170-kDa
forms and on the appearance of the 140-kDa forms following
FasL engagement. However, this led to the clear decrease of the
lower complexes (both 108- and 86/89-kDa) and a marked in-
crease in the 45/48-kDa forms. From these results, we could delin-
eate that the integrity of the actin cytoskeleton is mainly required
for the reduction of the complexes that exist before FasL engage-
ment (170- and 108-kDa), as well as the formation of the
86/89-kDa complex during apoptosis. In contrast, the integrity
of the microtubular cytoskeleton is mainly required for the stabil-
ity of the lower complexes, i.e., the 108- and 86/89-kDa forms.
Fig. 5. The role of microtubular cytoskeleton and caspase-8 in the Fas complex
formation. L1210.mFas cells were treated with NDZ and M2-crosslinked FasL for
3 h. The total lysate and the cytoskeleton fraction were then subjected to
immunoblotting with the indicated antibodies (a typical experiment of 4 is shown)
or to cell death assessment by sub-G1 measurement. The graph represents the
average of three independent cell death experiments, with error bars indicating S.D.
(A); Fas co-IP was carried out on the cytoskeleton fraction. The total lysate obtained
before cytoskeleton fractionation and the immunoprecipitates were then subjected
to immunoblotting. Antibody-conjugated beads served as control for non-speciﬁc
detection (ctrl) A typical experiment of 3 is shown (B).
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nents in the integrity and/or formation of the Fas complexes
(Figs. 4A and S3) suggests a possible sequential requirement of
the actin and microtubular cytoskeleton during the dynamics of
Fas complexes formation. Indeed, the observation that actin depo-
lymerization resulted in a similar effect to that of initiator caspases
inhibition (i.e restoring the 170- and 108-kDa forms while
inhibiting the 86/89-kDa form) may indicate that the actin cyto-
skeleton contributes to the complex formation process at the level
of the activation of initiator caspases. On the other hand, the effect
of tubulin depolymerization resembles the inhibition of caspase-3.
It inhibited the formation of the 86/89-kDa form without signif-
icantly restoring the 170-kDa forms. This may suggest a contribu-
tion of the microtubular cytoskeleton at the level of the
executioner caspase activation.
3.5. The association of Fas lower complexes, caspase-8 and
microtubule inﬂuences the apoptotic outcome
Having identiﬁed the roles of caspases and cytoskeletal compo-
nents in the Fas complex formation, we further examined the links
between these factors. We observed that the NDZ treatment re-
sulted in the reduced activation of caspase-8 and consequently re-
duced FasL-induced apoptosis (Fig. 5A). From the cytoskeleton
isolation, we observed that following FasL treatment, an active
form (43-kDa) of caspase-8 is recruited to the cytoskeleton fraction
and this recruitment was reduced upon tubulin depolymerization
by NDZ. Moreover both this active form of caspase-8 and tubulin
can be co-immunoprecipitated with the lower complexes of Fas
(Fig. 5B). This interaction is dependant on the tubulin polymeriza-
tion as it is lost in presence of NDZ. Furthermore our results sug-
gesting that the speciﬁc spatial arrangement of the microtubular
cytoskeleton, caspase-8 and Fas may affect the efﬁciency of the
activation of the caspase cascade (Fig. 5B). These ﬁndings are con-
sistent with a recent report that caspase-8 recruitment to the
microtubules promotes caspase-8-dependent apoptosis, and
microtubule stabilizing agent enhances this effect while microtu-
bule-destabilizing agent reduces it [21].
It should be noted that the reduced caspase activities due to
tubulin depolymerization (Fig. 5A) did not lead to the stabilization
of the lower complex at 108-kDa forms (Fig. 4A) as was the case
with caspase inhibitors (Fig. 3A). This suggests that the stabiliza-
tion of the 108-kDa form by the inhibition of caspase activities
is dependent on the integrity of the microtubules. Additionally, a
stronger reduction of the 108-kDa forms and the lack of the accu-
mulation of the 86/89-kDa form was linked to the drastic increase
in the 45/48-kDa form when the microtubules were disrupted
(Fig. 4A). This leads us to hypothesize on the role of the microtu-
bule network not only in the stabilization of Fas lower complexes
but also their formation from the 45/48-kDa form. It is possible
that the spatial stabilization of the 108-kDa form by intact micro-
tubules allows an efﬁcient formation of the 86/89-kDa form
which is mediated by the executioner caspase-3.
Thus far, only few studies have reported the contribution of
microtubules in the Fas apoptotic signal transduction from the
membrane level toward the execution. In a human hepatoma cell
line transiently transfected with Fas-GFP protein, it has been
shown that the treatment with FasL leads to the cytosolic forma-
tion of EGFR-Fas complex. This complex is subsequently translo-
cated to the plasma membrane by a microtubule-dependent
mechanism before the DISC formation [22]. GD3 ganglioside,
which can play a role in propagating Fas apoptotic signal [23]
has been shown to associate with microtubular cytoskeleton in a
human T cell line soon after Fas ligation by agonistic antibody.
The integrity of the microtubule plays an important role in the
redistribution of GD3 from the plasmamembrane to the mitochon-dria and possibly contributes to the mitochondrial alteration and
apoptosis [24,25].
Our study provides additional insight on the roles of microtu-
bules in the Fas-mediated apoptosis. The microtubular cytoskele-
ton stabilizes the organization of a subset of the Fas receptor,
which occurs in a caspase-dependent manner following the onset
of apoptosis. We showed that the complex of Fas lower aggregate,
microtubule and caspase-8 can contribute of the propagation of
the FasL-induced cell death. Our study reveals a novel contribution
of the microtubule in the Fas-induced apoptosis signaling, an area
in which current information remains scarce. A better understand-
ing of the involvement of microtubules in the Fas signaling path-
way is invaluable for developing well-targeted microtubule-
disrupting agents for use in cancer therapy.
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